CareLit CareLitFachliteratur für Gesundheitsberufe
CareLit · DOI-Nachweis · Diabetologie und Stoffwechsel

DPP-4 inhibitors enhance GIP and attenuate GLP-1 incretin effects during IVGTT in Wistar rats

EJ Freyse, S Berg, P Heinke, KD Kohnert, E Salzsieder · Diabetologie und Stoffwechsel · Ausgabe 04/2010

DOI 10.1055/s-0030-1253788

Bibliografische Angaben

Nachweis in CareLit

Autor:innenEJ Freyse, S Berg, P Heinke, KD Kohnert, E Salzsieder
ZeitschriftDiabetologie und Stoffwechsel
Ausgabe04/2010
Jahrgang / SeitenNicht angegeben

Kernaussage aus der Literatur

Abstract-Vorschau

Aims: DPP-4 (dipeptidyl peptidase-4) inhibition has been reported to increase incretin effects of GIP as well as GLP-1 by prolonging their half life. DPP-4 cleaves GIP into dipeptide and the GIP metabolite GIP (3–42), whereas the GLP-1 (7–36) amide is cleaved to GLP-1 (9–36) amide. Based on studies in man, pig and rat, these peptides are involved in various glucoregulatory processes. We have recently developed a tes…

Zitieren

Zitierempfehlung

EJ Freyse, S Berg, P Heinke, KD Kohnert, E Salzsieder (2010) DPP-4 inhibitors enhance GIP and attenuate GLP-1 incretin effects during IVGTT in Wistar rats. Diabetologie und Stoffwechsel (04). https://doi.org/10.1055/s-0030-1253788

Mit CareLit weiterarbeiten

Volltext, Abstract und ähnliche Literatur